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Abstract: Constructing pathways of tumor progression and discovering the biomarkers associated with cancer is critical 
for understanding the molecular basis of the disease and for the establishment of novel chemotherapeutic approaches and 
in turn improving the clinical efﬁ  ciency of the drugs. It has recently received a lot of attention from bioinformatics researchers. 
However, relatively few methods are available for constructing pathways. This article develops a novel entropy kernel based 
kernel clustering and fuzzy kernel clustering algorithms to construct the tumor progression pathways using CpG island 
methylation data. The methylation data which come from tumor tissues diagnosed at different stages can be used to distin-
guish epigenotype and phenotypes the describe the molecular events of different phases. Using kernel and fuzzy kernel 
kmeans, we built tumor progression trees to describe the pathways of tumor progression and ﬁ  nd the possible biomarkers 
associated with cancer. Our results indicate that the proposed algorithms together with methylation proﬁ  les can predict the 
tumor progression stages and discover the biomarkers efﬁ  ciently. Software is available upon request.
Keywords: progression pathway, kernel kmeans, fuzzy kernel kmeans, biomarkers
1. Introduction
DNA methylation is a post-replication modiﬁ  cation predominantly found in cytosines of the dinucleotide 
CpG that is infrarepresented throughout the genome except at small regions named CpG islands. It is 
noted that methylation events responsible for silencing critical tumor suppressor genes that lead to 
tumorigenesis can be captured in the DNA epigenetic code of a tumor. As DNA is heritable and stable, 
retrospective methylation analysis on samples collected earlier tends to provide more complete clinico-
pathological information. A few studies (Baylin, 2005; Robertson, 2005; Yan et al. 2001, Chen et al. 
2003, Wei et al. 2002) have reported that normally unmethylated CpG island (a short stretch of DNA in 
which the frequency of the CG sequence is higher than other region) located in the promoter region of 
cancer cells undergoes dense hypermethylation during tumor progression. Hypomethylation can also be 
found at different parts of the genome in cancer. The extent of both DNA hypomethylation and hyper-
methylation in the tumor cell is likely to reﬂect distinctive biological and clinical features. Researchers 
found that DNA hypermethylation and hypomethylation are independent processes and appear to play 
different roles in tumor progression (Frigola et al. 2005). Methylation of the CpG sites inﬂuences the 
activity of nearby genes and is critical to the regulation of gene expression. With the advances in high 
throughput technology, we can get the methylation signature of multiple genes simultaneously and clas-
sify tumors based on the global patterns of DNA methylation. In this research, we intend to show that 
solid tumor progression can be characterized by the progressive accumulation of epigenetic events.
We will concentrate on the hypermethylation analysis in this paper, even the proposed method can 
be applied to hypomethylation with little change. Several challenges we have to face in collecting and 
analyzing the multilocus hypermethylation data. First tumor tissues from different patients at different 
progression stages with distinct phenotypes have to be studied since it is difﬁ  cult to collect tumor tis-
sues of the same patient at different stages. Second we need to deﬁ  ne an appropriate similarity (distance) 
measure before we can cluster the epigenetic data and construct the pathway. Wang et al. (2006) have 
used the weighted Euclidian distance to deﬁ  ne the similarity of the binary hypermethylation data, which 
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is not quite appropriate. Finally we have to build 
the tumor progression pathway with both meth-
ylation and phenotype data and each node (cluster) 
should make biological sense.
Directed acyclic graphs (DAGs) or tree diagrams 
(Wang et al. 2007) have been used to represent 
possible tumor progression pathway. The main 
objectives of pathway construction is to construct 
patterns and relationships among hypermethylated 
genes that are progres  sively accumulated during 
tumorigenesis. Therefore the phenotypes of the 
progeny node in the pathway tree are supposed to 
be more aggressive than the parent nodes and the 
parent’s hypermethylated loci are inherited by their 
progeny nodes.
In this paper, we proposed a two-step pathway 
construction algorithm. First we deﬁ  ne a similar-
ity measure using normalized mutual information 
and cluster the data with the measure to ﬁ  nd the 
pathway nodes. Second we build the pathway tree 
based on the center of each cluster and the heri-
tability of the genotype and phenotype data. By 
ﬁ  rst clustering the genotype data, one reduces the 
number of multiple comparisons substantially. 
Moreover it is much more robust and more likely 
to be platform independent to look at aggregates 
of genes (clusters). Most importantly combining 
the genotypes along pathways is biologically 
meaningful. Pathways are closer to the clinical 
phenotype than the individual constituents of 
these pathways. The whole is usually more than 
the sum of its parts.
This paper is organized as follows. In section 2, 
we develop the clustering procedures for pathway 
construction. We construct a pathway and dis-
cover the associated biomarkers with real data in 
section 3. Conclusions and discussions are given 
in section 4.
2. Methods
Kernel based clustering
Data clustering algorithms partition the data into 
pre-speciﬁ  ed number of groups such that a well 
deﬁ  ned cost function is minimized. Many cluster-
ing algorithms have been developed in recent 
years. The most well-known and widely used 
algorithm is the iterative relocation scheme of 
Euclidean kmeans (Jain and Dubes, 1988). The 
popularity of this algorithm stems from its simplic-
ity and scalability. However the squared-Euclidean 
cost function of kmeans is not a good match with 
the data and consequently kmeans performs poorly 
as compared with other approaches (Strehl, 2000). 
Another major drawback of kmeans is that it can 
not separate clusters that are nonlinearly separable 
in the input space. All of these have lead to the 
search for more appropriate distance (similarity) 
functions (Aggarwal, 2003; Strehl et al. 2000). 
Entropy based distance measure has been used for 
text classiﬁ  cation (Dhillon et al. 2003).
Data produced by methylation array are binary 
in nature (1: hypermethylated; 0: unmethylated) 
for which clustering based on Euclidean distance 
is not meaningful. In this paper we propose the 
mutual information based distance (similarity) 
function which capture the nonlinear correlation 
between the variables. We deﬁ  ne an entropy kernel 
by introducing the normalized mutual information. 
Mutual information also called Kullback-Leibler 
(KL) divergence (Kullback and Leibler, 1951) was 
ﬁ  rst proposed to measure the distance between two 
probability distributions. Unlike correlation coef-
ﬁ  cient, mutual information captures both the linear 
and nonlinear correlations. Give two sequences 
x and y, the normalized mutual information is 
deﬁ  ned as (Liu and Chen, 2005):
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where h(x) = –Σi
 p(xi) log 
1
px i ()  is the entropy for 
sequence x and h(y) is the entropy for sequence 
y and 0  K(x,y)  1. K(x,y) = 0 when two 
sequences are independent and K(x,y) = 1 when 
they are completely correlated. K(x,y) is also 
symmetric with respect to the two sequences 
x and y.
It follows from the Mercer’s theorem that Equa-
tion (1) deﬁ  nes a kernel function. To form a kernel 
function, data points are mapped to a higher-
dimensional feature space using a nonlinear func-
tion φ (x), then a kernel function is formed with the 
inner product, K(x,y) = φ (x)
tφ (y), where Φ (x)
t is 
the transpose of φ (x). However we can deﬁ  ne a 
kernel function directly as in Equation (1) without 
knowing the transformation function φ (x) explic-
itly. Kernel kmeans partitions the data in the new 
feature space with the kernel matrix.
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Given a set of input data x1, x2,... , xn, the kernel 
kmeans algorithm seeks to ﬁ  nd clusters C1,C2,... ,Ck 
that minimize the objective (error) function:
where
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Note the ﬁ  nal result of Equation (3) is associated 
with kernel values only. It can be shown that ker-
nel kmeans algorithm is equivalent to spectral 
clustering and graph partitioning (Dhillon et al. 
2005). Spectral clustering is a eigenvector-based 
algorithm with kernel prin  cipal analysis, which 
can be computationally prohibitive. It also has the 
drawback that the number of eigenvectors used 
has to be predetermined. The equivalence of kernel 
kmeans and kernel principal component clustering 
implies that we can use the iteration algorithms 
for directly minimizing normalized-cut of graph. 
Therefore kernel kmeans is more computa  tional 
efﬁ  cient. With Equation (3), the standard kmeans 
iteration procedure can be applied without any 
difficulty. Details of the algorithm are given 
below:
Kernel Kmean algorithm
•    Calculating the kernel matrix K with the epi-
genetic data. Given the number of clusters k, 
the optional maximum number of iterations, 
and optional initial clusters:
  1.  Initialize the k clusters  () () 00
1 ,…, k CC  randomly
   if no initial clustering is given. Set t = 0.
  2. for each sample xi and each cluster p,
   compute
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  3. Update the clusters through sending xi to
   cluster  p* such that p* = arg minp d(xi, mp).
 4.  continue  t = t + 1 until mp is converged or
   the maximum iteration is exceeded.
•    Output the ﬁ  nal clusters.
Fuzzy kernel kmeans
The hard partitioning kernel kmeans is simple and 
popular, but its results are not always re  liable and 
these algorithms have numerical problems as well. 
Fuzzy kernel kmeans algorithm is a generalization 
of kernel kmean. It minimizes the following error 
function:
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function is minimized only if
 µpi
j
k
pi ji
q
dd
pk in =
( )
≤≤ ≤ ≤
=
− ()
1
11
1
11
Σ
,,  
(4)
and
  m p
i
n
pi
q
i
i
n
pi
q pk =≤ ≤
=
=
ΣΦ
Σ
1
1
1
µ
µ
()
,.
x
 (5)
m
x x
p
Ci
p
ip
C
=
∈ Σ φ()
Cancer Informatics 2008:6 4
Liu et al
We have the squared distance
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The algorithm:
•   Calculating the kernel matrix K with the epi-
genetic data. Given the number of clusters k, 
the optional maximum number of iterations, and 
the termination tolerance ε  0.
  1. Initialize the partition matrix U  
0 = [µpi] k×n,
  and set t = 0.
  2. Compute the distances:
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  3. Update the partition matrix:
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  4. Stop until ||U
t − U
t−1|| < ε
Cluster validation
The number of clusters is predeﬁ  ned in the two 
kernel kmeans algorithm. There is no generally 
accepted procedure for determining the number of 
clusters. This decision should be guided by theory 
and practicality of the results, along with the use 
of the inter-cluster distances at successive steps. 
The distance between two samples can be calcu-
lated with d (xi, xj) = K(xi, xi) + K(xj, xj) − 2K(xi, xj). 
One approach to determining the number of clus-
ters is to utilize the validation function. Different 
validity measures have been proposed in the 
literature, non of them is perfect by itself. We have 
utilized Dunn’s index (DI) to determine the number 
of clusters.
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The number of clusters is chosen with the maximal 
DI value.
3. Pathway Discovery
The clusters found with kernel kmenas can be used 
as the nodes of the pathway tree. We can build the 
pathway with the centers of genotype and phenotype 
data of each cluster. Because both genotype and 
phenotype data are ordinal in nature, their centers 
are deﬁ  ned to be the medians of each cluster. Given 
K genotype centers  GCi i
K {} =1 and phenotype centers 
PCi i
K {} =, the tumor progression tree are built with 
the heritability of each node, i.e. a child node j from 
its parent node i must satisfy GCj ≥ GCi and PCj ≥ 
PCi. Under this condition, all hypermethylated loci 
in a parent node is inherited by its progeny node and 
the progeny node has at least the same serious phe-
notype condition as its parent node.
Computational experiments
Our experiments are performed with the methyla-
tion data of 50 breast carcinomas of unrelated 
patients (http://www.stat.ohio-state.edu/statgen/). 
There are 9 genes for their methylation status 
(0: unmethylated; 1: hypermethylated). The 9 genes 
are: GPC3 RASSF1A, WT1, uPA, HOXA5, p16, 
3OST3B, BRCA1, and DAPK1. The 4 phenotype 
measurements used in our analysis are ER/PR 
(1: +/+; 2: +/–; 3; –/–), histology (1: well-differentiated, 
WD; 2: moderately-differentiated, MD; 3: poorly-
differentiated, PD), clinical stage (1, 2, 3, or 4), and 
metastasis status (0, M0; 1, M1). We exclude age 
from the phenotype data since it is not a strong 
cancer indicator. We ﬁ  nd the cluster nodes either 
solely with epigenetic data or with the phenotype 
and epigenetic data together. Because the aim of 
clustering is to group the samples into different 
clusters, only one dataset is used. The cluster is 
validated with Dunn’s index (DI).
Clustering with kernel Kmeans
In this approach, we ﬁ  rst ﬁ  nd the clusters (nodes) 
based on epigenetic data and kernel Kmeans, and 
Cancer Informatics 2008:6 5
Biomarker discovery with fuzzy kernel kmeans and DNA methylation data
then the node centers are estimated to be the 
median of the phenotype and genotype within each 
cluster. We then build the pathway based on nodes 
heritability. The output for the node centers are 
given in Table (1).
Based on the node centers, the pathway tree 
built with the proposed algorithm is given in 
Figure (1). In Figure (1), the green spots represent 
the unmethylated loci and the red spots are the 
hypermethylated loci. The gene name of each locus 
is shown in the upper right corner of the ﬁ  gure. 
The numbers beside each node plot are the pheno-
type centers (medians).
Fuzzy kernel Kmeans
We also found the nodes (clusters) with fuzzy kernel 
Kmeans and genotype data. There is one more clus-
ter (node) in the tumor progression tree and multiple 
pathways with Fuzzy kernel Kmeans. Figure (2) is 
the corresponding progression pathway.
Results
The progression Pathways presented both in 
Figure (1) and Figure (2) validate the notion that 
tumors with more aggressive phenotypes should 
have higher level of methylation than that with 
less aggressive phenotypes. The ﬁ  rst phenotype 
is the Hormone receptor status (ER/PR). The 
progression becomes more aggressive when more 
hypermethylation happened among the 9 genes. 
The other two phenotypes, histology and clinical 
stage, have the similar trend to progress from 
lower stage to higher stage in both progression 
trees. Metastasis happened in the terminal nodes 
of the pathways.
The hypermethylation in the promoters of GPC3 
and RASSF1A happened in several intermediate 
and terminal nodes of both trees. This is consistent 
with the observation that a large number of tumors 
have concurrent hypermethylation of GPC3 and 
RASSF1A. The progression pathways also 
indicated that hypermethylation in the promoter of 
Table 1. Node centers of genotype and phenotype 
data.
Genotype center   phenotype center
1 1 1 0 1 0 0 0 0   2 2 3 0
1 1 0 0 0 0 1 1 0   3 2 4 1
1 1 1 1 1 0 0 0 0   2 2 2 0
0 1 0 0 0 0 0 0 0   1 2 2 0
1 1 0 1 0 0 1 0 0   1 2 2 0
1 0 0 0 0 0 0 1 0   2 2 2 0
1 1 0 1 0 0 0 0 0   1 2 2 0
0 1 0 0 1 1 1 0 0   1 2 2 0
1 0 1 1 0 0 0 0 0   1 2 2 0
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Figure 1. Progression pathway clustered with kernel kmeans.
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4 genes: 3OST3B, BRCA1, GPC3, and RASSF1A, 
leads to the most aggressive tumors whereas 
methylation in other genes has much less effect. 
Therefore, genes 3OST3B and BRCA1 should be 
studied carefully in functional analysis. Another 
gene HOXA5 may also play an important role in 
tumor aggression. Fuzzy kernel Kmeans seems to 
perform better in the sense that it ﬁ  nds one more 
node and multiple pathways.
4. Conclusions and Remarks
We proposed an entropy kernel and kernel based 
algorithm for recapitulating tumor progres  sion 
pathway and biomarker ﬁ  nding. The proposed 
fuzzy kernel kmean algorithm seems to perform 
better than the standard kernel kmean, since the 
DI for fuzzy kernel kmeans (0.52) is greater than 
that for kernel kmeans (0.41). It can also provides 
multiple pathways. In the constructed progression 
tree, the progeny nodes have more hypermethyl-
ated gene promoters than its parent nodes and the 
progeny node has more aggressive tumor than its 
parents. The proposed method can not only 
discover different tumor progression paths but 
also ﬁ  nd genes (biomarkers) that lead to more 
aggressive tumors and have biological and clinical 
signiﬁ  cance. Fuzzy kernel Kmean algorithm is a 
novel idea that is not found in the current litera-
ture. The proposed algorithms can be applied to 
analyze hypomethylation data and build corre-
sponding pathways with little revision. With 
appropriate kernel functions, the method can be 
utilized to analyze other sequential and microar-
ray data.
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